3 more drugmakers recall metformin due to carcinogen

After the FDA said in May that it found unacceptable levels of a carcinogen in popular diabetes drug metformin, several drugmakers began recalling their metformin products. 

Advertisement

As of August, 10 drugmakers had recalled their metformin products. Since then, three more drugmakers have either expanded their recall or announced a new recall: 

  1. Bayshore Pharmaceuticals is recalling one lot of its metformin pills.
  2. Marksans Pharma is expanding its earlier recall to include an additional 76 lots of metformin pills.
  3. Sun Pharmaceuticals is recalling one lot of its metformin pills.

Find a full list of all recalled lots of metformin here.

More articles on pharmacy:
7 key uncertainties surrounding the COVID-19 vaccine race
Mallinckrodt files for Chapter 11 bankruptcy
Operation Warp Speed czar: Vaccine approval likely to be sought around Thanksgiving

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.